| Accession | ARO:3001826 |
| CARD Short Name | ACT-9 |
| Definition | ACT-9 is a beta-lactamase found in Pantoea agglomerans. |
| AMR Gene Family | ACT beta-lactamase |
| Drug Class | cephalosporin, penam, cephamycin, carbapenem |
| Resistance Mechanism | antibiotic inactivation |
| Resistomes with Sequence Variants | Enterobacter kobeig+wgs |
| Classification | 16 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + antibiotic molecule + antibiotic inactivation [Resistance Mechanism] + determinant of antibiotic resistance + beta-lactam antibiotic + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + hydrolysis of beta-lactam antibiotic by serine beta-lactamase + beta-lactamase + cephem + cephalosporin [Drug Class] + class C beta-lactamase + penam [Drug Class] + cephamycin [Drug Class] + carbapenem [Drug Class] |
| Parent Term(s) | 1 ontology terms | Show + ACT beta-lactamase [AMR Gene Family] |
| Publications | Lee YT, et al. 2011. Antimicrob Agents Chemother 55(9): 4440-4442. Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem. (PMID 21690276) |
Prevalence of ACT-9 among the sequenced genomes, plasmids, and whole-genome shotgun assemblies available at NCBI or IslandViewer for 413 important pathogens (see methodological details and complete list of analyzed pathogens). Values reflect percentage of genomes, plasmids, genome islands, or whole-genome shotgun assemblies that have at least one hit to the AMR detection model. Default view includes percentages calculated based on Perfect plus Strict RGI hits. Select the checkbox to view percentages based on only Perfect matches to AMR reference sequences curated in CARD (note: this excludes resistance via mutation as references in protein variant models are often wild-type, sensitive sequences).
| Species | NCBI Chromosome | NCBI Plasmid | NCBI WGS | NCBI GI |
|---|---|---|---|---|
| Enterobacter kobei | 9.09% | 0% | 11.79% | 0% |
Model Type: protein homolog model
Model Definition: Protein Homolog Models (PHM) detect protein sequences based on their similarity to a curated reference sequence, using curated BLASTP bitscore cut-offs. Protein Homolog Models apply to all genes that confer resistance through their presence in an organism, such as the presence of a beta-lactamase gene on a plasmid. PHMs include a reference sequence and a bitscore cut-off for detection using BLASTP. A Perfect RGI match is 100% identical to the reference protein sequence along its entire length, a Strict RGI match is not identical but the bit-score of the matched sequence is greater than the curated BLASTP bit-score cutoff, Loose RGI matches have a bit-score less than the curated BLASTP bit-score cut-off.
Bit-score Cut-off (blastP): 700